基本信息
views: 67
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Palena’s research focuses on the immunological targeting of drivers of tumor metastasis and resistance to therapy. Her recent studies on a novel tumor-associated antigen, the transcription factor brachyury, have led to the rapid translation of 3 cancer vaccine platforms targeting a driver of the epithelial-mesenchymal transition, a process associated with cancer progression, from basic discovery to Phase I and II clinical studies.
As the Head of the Immunoregulation Section, Dr. Palena continues to investigate innovative immunotherapeutic approaches that may be used in combination with other anti-neoplastic agents to generate anti-tumor immune responses that could alleviate metastatic disease in cancer patients.
As the Head of the Immunoregulation Section, Dr. Palena continues to investigate innovative immunotherapeutic approaches that may be used in combination with other anti-neoplastic agents to generate anti-tumor immune responses that could alleviate metastatic disease in cancer patients.
Research Interests
Papers共 179 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal for immunotherapy of cancerno. 7 (2024)
Maria Del Mar Maldonado,Masafumi Iida, Maria Del Mar Gracia Hernandez, Loc Le,Renee N. Donahue,Claudia Palena,Jeffrey Schlom,Duane H. Hamilton
Cancer Researchno. 6_Supplement (2024): 4092-4092
Regular and Young Investigator Award Abstracts (2023)
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
Load More
Author Statistics
#Papers: 183
#Citation: 5705
H-Index: 41
G-Index: 74
Sociability: 8
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn